136 related articles for article (PubMed ID: 31233340)
1. QSAR Classification-Based Virtual Screening Followed by Molecular Docking Identification of Potential COX-2 Inhibitors in a Natural Product Library.
Ai S; Lin G; Bai Y; Liu X; Piao L
J Comput Biol; 2019 Nov; 26(11):1296-1315. PubMed ID: 31233340
[No Abstract] [Full Text] [Related]
2. QSAR classification-based virtual screening followed by molecular docking studies for identification of potential inhibitors of 5-lipoxygenase.
Shameera Ahamed TK; Rajan VK; Sabira K; Muraleedharan K
Comput Biol Chem; 2018 Dec; 77():154-166. PubMed ID: 30321850
[TBL] [Abstract][Full Text] [Related]
3. Identification of COX-2 inhibitors via structure-based virtual screening and molecular dynamics simulation.
Razzaghi-Asl N; Mirzayi S; Mahnam K; Sepehri S
J Mol Graph Model; 2018 Aug; 83():138-152. PubMed ID: 29936228
[TBL] [Abstract][Full Text] [Related]
4. Computer-aided identification of natural lead compounds as cyclooxygenase-2 inhibitors using virtual screening and molecular dynamic simulation.
Ounissi M; Kameli A; Tigrine C; Rachedi FZ
Comput Biol Chem; 2018 Dec; 77():1-16. PubMed ID: 30195234
[TBL] [Abstract][Full Text] [Related]
5. 3D-QSAR and Molecular Docking Studies on Oxadiazole Substituted Benzimidazole Derivatives: Validation of Experimental Inhibitory Potencies Towards COX-2.
Asati V; Ghode P; Bajaj S; Jain SK; Bharti SK
Curr Comput Aided Drug Des; 2019; 15(4):277-293. PubMed ID: 30280671
[TBL] [Abstract][Full Text] [Related]
6. Matrix-based Molecular Descriptors for Prospective Virtual Compound Screening.
Grisoni F; Reker D; Schneider P; Friedrich L; Consonni V; Todeschini R; Koeberle A; Werz O; Schneider G
Mol Inform; 2017 Jan; 36(1-2):. PubMed ID: 27650559
[TBL] [Abstract][Full Text] [Related]
7. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
8. Docking-based 3D-QSAR (CoMFA, CoMFA-RG, CoMSIA) study on hydroquinoline and thiazinan-4-one derivatives as selective COX-2 inhibitors.
Dowlati Beirami A; Hajimahdi Z; Zarghi A
J Biomol Struct Dyn; 2019 Jul; 37(11):2999-3006. PubMed ID: 30035675
[TBL] [Abstract][Full Text] [Related]
9. Studies of the benzopyran class of selective COX-2 inhibitors using 3D-QSAR and molecular docking.
Yadav DK; Saloni ; Sharma P; Misra S; Singh H; Mancera RL; Kim K; Jang C; Kim MH; Pérez-Sánchez H; Choi EH; Kumar S
Arch Pharm Res; 2018 Dec; 41(12):1178-1189. PubMed ID: 28822076
[TBL] [Abstract][Full Text] [Related]
10. Extraction and visualization of potential pharmacophore points using support vector machines: application to ligand-based virtual screening for COX-2 inhibitors.
Franke L; Byvatov E; Werz O; Steinhilber D; Schneider P; Schneider G
J Med Chem; 2005 Nov; 48(22):6997-7004. PubMed ID: 16250658
[TBL] [Abstract][Full Text] [Related]
11. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
12. Novel pyrazoline derivatives as bi-inhibitor of COX-2 and B-Raf in treating cervical carcinoma.
Yu M; Yang H; Wu K; Ji Y; Ju L; Lu X
Bioorg Med Chem; 2014 Aug; 22(15):4109-18. PubMed ID: 24934992
[TBL] [Abstract][Full Text] [Related]
13. Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity.
Coy-Barrera E
Biomolecules; 2020 Jan; 10(2):. PubMed ID: 31979339
[TBL] [Abstract][Full Text] [Related]
14. In silico exploration of c-KIT inhibitors by pharmaco-informatics methodology: pharmacophore modeling, 3D QSAR, docking studies, and virtual screening.
Chaudhari P; Bari S
Mol Divers; 2016 Feb; 20(1):41-53. PubMed ID: 26416560
[TBL] [Abstract][Full Text] [Related]
15. Atom Based 3D-QSAR, Molecular Docking and Density Functional Theory Approaches to Identify Novel JNK-1 Inhibitor.
Shylaja R; Kavitha R; Meganathan C
Comb Chem High Throughput Screen; 2016; 19(9):771-797. PubMed ID: 27585829
[TBL] [Abstract][Full Text] [Related]
16. The study of dual COX-2/5-LOX inhibitors by using electronic-topological approach based on data on the ligand-receptor interactions.
Aksakal F; Shvets N; Dimoglo A
J Mol Graph Model; 2015 Jul; 60():79-88. PubMed ID: 26117823
[TBL] [Abstract][Full Text] [Related]
17. Precise cuts for tailoring chromene-phenyl COX inhibitors with Ligand Designer.
Vo HHN; Phung THT; Chung KL; Vu TY
J Mol Graph Model; 2024 Jun; 129():108747. PubMed ID: 38447296
[TBL] [Abstract][Full Text] [Related]
18. The effect of various atomic partial charge schemes to elucidate consensus activity-correlating molecular regions: a test case of diverse QSAR models.
Kumar SP; Jha PC; Jasrai YT; Pandya HA
J Biomol Struct Dyn; 2016; 34(3):540-59. PubMed ID: 25997097
[TBL] [Abstract][Full Text] [Related]
19. Discovery of a potent cyclooxygenase-2 inhibitor, S4, through docking-based pharmacophore screening, in vivo and in vitro estimations.
Tseng TS; Chuang SM; Hsiao NW; Chen YW; Lee YC; Lin CC; Huang C; Tsai KC
Mol Biosyst; 2016 Jul; 12(8):2541-51. PubMed ID: 27265567
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study.
El-Sayed MA; Abdel-Aziz NI; Abdel-Aziz AA; El-Azab AS; Asiri YA; Eltahir KE
Bioorg Med Chem; 2011 Jun; 19(11):3416-24. PubMed ID: 21570309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
